Company Overview and News

8
Exelixis' Partner Ipsen Gets Approval for Cabometyx in Canada

2018-09-20 zacks
Exelixis, Inc. (EXEL - Free Report) along with its partner Ipsen Biopharmaceuticals Canada announced that Health Canada has approved Cabometyx (cabozantinib) tablets for the treatment of advanced renal cell carcinoma (RCC) in adult patients, previously treated with vascular endothelial growth factor targeted therapy.
WFC WFCNP EXEL GILD RHT NVS CSIQ

9
Accenture (ACN) Builds Innovation Center for Salesforce

2018-09-20 zacks - 1
Accenture plc (ACN - Free Report) yesterday announced the launch of Innovation Center for Salesforce (CRM - Free Report) . The center focuses on demonstrating new ways of applying Salesforce technologies to improve end-user experiences, capture data through transactions and deliver value for customers. Service bots and artificial intelligence (Salesforce Einstein AI) as well as virtual reality-based demonstrations will be used for visual storytelling and interactive demonstrations across industries.
WFC WFCNP FCN RHT ACN CSIQ CRAI

61
Equinor Hires West Hercules Rig for Drilling in Barents Sea

2018-09-20 zacks
Equinor ASA (EQNR - Free Report) has awarded a drilling contract to a subsidiary of Seadrill Ltd. SDRL, Seadrill Norway Operations Ltd, for the use of semi-submersible rig, West Hercules. The contract relates to drilling of two exploration wells in the Barents Sea with options for drilling nine additional wells. Drilling is anticipated to commence in the spring of 2019. The rig is mainly allocated for exploration drilling.
HLX WFC WFCNP SDLP XOM RHT SDRL CSIQ

16
Abbott Banks on New Approvals and Buyouts, Competition Rife

2018-09-20 zacks
On Sep 19, we issued an updated research report on Abbott Laboratories (ABT - Free Report) . Notably, branded generics and international diabetes businesses of Abbott should drive growth in the coming quarters. Nevertheless, a competitive environment persists to raise concerns for Abbott. The stock carries a Zacks Rank #3 (Hold).
ABT WFC WFCNP ISRG ABT RHT VEEV ATHN CSIQ

7
Ultragenyx's Shares Surge More Than 80% in the Year So Far

2018-09-20 zacks
The share price of Ultragenyx Pharmaceutical Inc. (RARE - Free Report) has surged 85.2% year to date against the industry’s decline of 4.7%.
WFCNP LGNDZ LGNYZ CSIQ WFC GILD RARE RHT LGNZZ LGND LGNXZ

7
Praxair & Linde to Sell Assets for U.S. Antitrust Approval

2018-09-20 zacks
Praxair Inc. (PX - Free Report) and Linde AG have entered into an agreement to sell additional assets to a consortium of Messer Group GmbH and CVC Capital Partners. With this, the companies have moved a step ahead toward obtaining the U.S. antitrust approval, currently the major hurdle for the Praxair-Linde merger. Previously, Praxair and Linde had agreed to sell U.S. assets of the former, worth $3 billion, to Messer Group — a German industrial-gas supplier — and CVC — a private equity group — in a bid to secure U.
WFCNP 4091 NGVT.WI 523457 CSIQ CE WFC LINDEINDIA NGVT RHT PX

8
Red Hat (RHT) Q2 Earnings Beat, Revenues Miss Estimates

2018-09-20 zacks
Red Hat Inc. (RHT - Free Report) reported second-quarter fiscal 2019 non-GAAP earnings of 85 cents per share, surpassing the Zacks Consensus Estimate by 4 cents. The figure increased 24% on a year-over-year basis, primarily driven by strong top-line growth. Revenues increased 13.7% year over year to $822.7 million, primarily driven by strong demand for hybrid cloud technology solutions as well as aggressive cross-selling.
WFC WFCNP HDP CRM RHT CSIQ

7
Canadian Solar to Expand in Spain With 164MW Solar Project

2018-09-20 zacks
Canadian Solar Inc. (CSIQ - Free Report) recently announced its contract win to supply 164 megawatts (MW) of solar photovoltaic (PV) modules for the Escatrón Solar power project, which has a total capacity of 350 megawatts peak (MWp) and is owned by COBRA Group, a subsidiary of ACS Group in Spain. The company will supply nearly 481,900 high-efficiency MaxPower modules (CS6U-P 345/350 W) for this project.
WFC WFCNP OMP SHLX CSIQ

8
Canadian Solar (CSIQ) Up 13.3% Since Last Earnings Report: Can It Continue?

2018-09-13 zacks
It has been about a month since the last earnings report for Canadian Solar (CSIQ - Free Report) . Shares have added about 13.3% in that time frame, outperforming the S&P 500.
OXY CSIQ

4
Enphase Energy to Expand Manufacturing Operation in Mexico

2018-09-13 zacks
Enphase Energy, Inc. (ENPH - Free Report) has announced that its manufacturing facility in Mexico has expanded with its agreement with Flex Ltd. (FLEX - Free Report) . As per the agreement, starting from second-quarter 2019, Flex will begin delivering products produced by the company’s facility in Mexico to the U.S. market. Solar Outlook: Holds Promise for Microinverter Per U.S. Energy Information Administration (“EIA”), the source of energy from renewables increased over the years.
ENPH CSIQ

41
Short Sellers Jump on One Solar, One Alt Energy Stock

2018-09-13 247wallst - 1
Short interest moves among solar and alternative energy stocks were mixed during the two-week reporting period that ended on August 31. Of the companies we watch, short interest rose on two of three solar stocks and rose on three of five alternative energy stocks. We’ve added fuel cell maker Bloom Energy to our watch list this week.
SPWR CLNE BE FCELB 5GD SRGRF PEIX FSLR CSIQ PLUG FCEL

3
Australia states power ahead with renewables after national policy collapses

2018-09-11 reuters
MELBOURNE (Reuters) - Australia’s Victoria state on Tuesday agreed to back six new wind and solar farms to help meet a target of getting 25 percent of its power from renewables by 2020, just weeks after a year-long attempt at crafting a national energy policy collapsed.
CSIQ

7
Rising From The Solar Ashes: Jinko And Daqo Lead The Low-Cost Solar Revolution

2018-09-10 seekingalpha
With one-third of silicon producers unable to produce at a profit, Daqo seized market share while Jinko stockpiled super-cheap silicon.
JKS DQ SOL CSIQ JASO

3
General Dynamics Unit Wins $219M Deal to Repair USS Bonhomme

2018-09-07 zacks
General Dynamics Corp.’s (GD - Free Report) subsidiary, National Steel and Shipbuilding Co. (NASSCO), recently secured a contract for performing fiscal 2018 docking phased maintenance work on the USS Bonhomme Richard (LHD 6) assault ship. The task is expected to be completed by May 2020.
AJRD GD WU HII EGL CSIQ

9
Five Below (FIVE) Up on Q2 Earnings & Sales Beat, Lifted View

2018-09-07 zacks
Shares of Five Below, Inc. (FIVE - Free Report) rose roughly 10% during after-market trading on Sep 6, marking the continuation of a remarkable streak of positive earnings and sales surprises with the second quarter of fiscal 2018. The company also maintained a decent year-over-year improvement in both the top and bottom lines, with the seventh successive quarter of comparable-store sales growth. The figures not only surpassed analysts’ expectations but also beat management’s guidance.
WU SCVL URBN FIVE CSIQ BOOT

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 136635109